Search results
Johnson & Johnson (NYSE:JNJ) Shares Sold by Natixis Advisors L.P.
ETF DAILY NEWS· 3 days agoNatixis Advisors L.P. decreased its holdings in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 5.5% in the 4th quarter, according to its most recent Form 13F filing ...
Earnings call: Agenus secures $100 million, eyes Phase 3 cancer study
Investing.com· 4 days agoThis strategic move is intended to support the development of Agenus' BOT/BAL program, including a...
DLH Holdings Corp. (NASDAQ:DLHC) Q2 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 6 days agoDLH Holdings Corp. (NASDAQ:DLHC) Q2 2024 Earnings Call Transcript May 3, 2024 DLH Holdings Corp....
Earnings call: Kamada Limited reports robust Q1 2024 growth
Investing.com· 2 days agoKamada Limited (NASDAQ: KMDA ), a specialty biopharmaceutical company, has reported a strong start...
MDxHealth SA (NASDAQ:MDXH) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 days agoMDxHealth SA (NASDAQ:MDXH) Q1 2024 Earnings Call Transcript May 4, 2024 MDxHealth SA isn’t one of...
The AI Health Revolution Is Already Here
Women's Health via Yahoo News· 4 days agoAI has been integrated into our health care in big and less-apparent ways. Here's what experts say about how AI could play a role in our future health...
The Many Reinventions of a Legendary Washington Influence Peddler
Politico via Yahoo Finance· 5 days agoIn 2010, for instance, Morris and Courtovich teamed up when the FDA moved to rescind its approval of one of Genentech’s most profitable products — Avastin — for breast cancer
Veru Reports Fiscal 2024 Second Quarter Financial Results and Progress of its Enobosarm High Quality...
Morningstar· 2 days ago--Phase 2b clinical study of enobosarm in combination with semaglutide (Wegovy®*) for high quality weight loss is actively enrolling-- --Company assembles esteemed high quality weight loss Scientific ...
Johnson & Johnson (NYSE:JNJ) Shares Sold by First National Trust Co
ETF DAILY NEWS· 2 days agoFirst National Trust Co trimmed its holdings in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 10.1% in the 4th quarter, according to the company in its most recent 13F filing with ...
BioNTech Target of Unusually Large Options Trading (NASDAQ:BNTX)
ETF DAILY NEWS· 3 days agoBioNTech SE (NASDAQ:BNTX – Get Free Report) was the recipient of some unusual options trading on Monday. BMO Capital Markets cut their price objective on BioNTech from $123.00 to $122.00 and ...